RU93058393A - ETHANOLAMINE DERIVATIVES THAT DISTRIBUTE SYMPATHOMOMETIC AND ANTIPOLAKIURIAL ACTIVITY, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT - Google Patents

ETHANOLAMINE DERIVATIVES THAT DISTRIBUTE SYMPATHOMOMETIC AND ANTIPOLAKIURIAL ACTIVITY, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT

Info

Publication number
RU93058393A
RU93058393A RU93058393/04A RU93058393A RU93058393A RU 93058393 A RU93058393 A RU 93058393A RU 93058393/04 A RU93058393/04 A RU 93058393/04A RU 93058393 A RU93058393 A RU 93058393A RU 93058393 A RU93058393 A RU 93058393A
Authority
RU
Russia
Prior art keywords
group
additionally substituted
acyl
activity
pharmaceutical composition
Prior art date
Application number
RU93058393/04A
Other languages
Russian (ru)
Other versions
RU2125983C1 (en
Inventor
Сиокава Юити
Нагано Масанобу
Танигути Кийоси
Таке Казухико
Като Такеси
Тсубаки Казунори
Original Assignee
Фудзисава Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929202236A external-priority patent/GB9202236D0/en
Application filed by Фудзисава Фармасьютикал Ко., Лтд. filed Critical Фудзисава Фармасьютикал Ко., Лтд.
Priority claimed from PCT/JP1993/000113 external-priority patent/WO1993015041A1/en
Publication of RU93058393A publication Critical patent/RU93058393A/en
Application granted granted Critical
Publication of RU2125983C1 publication Critical patent/RU2125983C1/en

Links

Claims (1)

В изобретении рассматриваются новые производные этаноламина, обладающие по отношению к кишечнику селективной симпатомиметической активностью и активностью против учащенного мочеиспускания, которые могут быть предоставлены в виде общей формулы
Figure 00000001

где R1 - арильная или гетероциклическая группа, каждая из которых может содержать такие заместители, как атом галогена и т.д.; R2 - атом водорода, атом галогена, нитро-группа, оксигруппа, низшая алкильная группа, дополнительно замещенная ацильной группой, низшая алкенильная группа, дополнительно замещенная ацильной группой, низшая алкоксигруппа, дополнительно замещенная ацильной группой, или амино-группа, дополнительно замещенная ацил (низшей) алкильной группой; R3 - атом водорода, N - защитная группа или низшая алкильная группа, дополнительно замещенная низшей алкилтио-группой, n - целое число от 0 до 3, а жирная линия означает простую связь или двойную связь, при этом, если в равняется 1, то R1 - конденсированная ароматическая углеводородная группа или гетероциклическая группа, каждая из которых может содержать такие заместители, как галоген и т.д. и т.п.; и их фармацевтически приемлимые соли, способы получения указанных соединений и фармацевтическая композиция, включающая указанные соединения.
The invention considers new ethanolamine derivatives with selective sympathomimetic activity and activity against urinary frequency of urine, which can be provided as a general formula
Figure 00000001

where R 1 is an aryl or heterocyclic group, each of which may contain substituents such as a halogen atom, etc .; R 2 is a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a lower alkyl group additionally substituted by an acyl group, a lower alkenyl group additionally substituted by an acyl group, a lower alkoxy group additionally substituted by an acyl group, or an amino group additionally substituted by acyl ( lower) alkyl group; R 3 is a hydrogen atom, N is a protecting group or a lower alkyl group additionally substituted by a lower alkylthio group, n is an integer from 0 to 3, and the bold line denotes a simple bond or a double bond, while if equals 1, then R 1 is a condensed aromatic hydrocarbon group or a heterocyclic group, each of which may contain substituents such as halogen, etc. etc.; and their pharmaceutically acceptable salts, methods for producing these compounds, and a pharmaceutical composition comprising these compounds.
RU93058393A 1992-02-03 1993-02-01 Ethanolamine derivatives, method of their synthesis, pharmaceutical composition, method of treatment RU2125983C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929202236A GB9202236D0 (en) 1992-02-03 1992-02-03 New ethanolamine derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
GB9202236.7 1992-02-03
GB9217991.0 1992-08-24
PCT/JP1993/000113 WO1993015041A1 (en) 1992-02-03 1993-02-01 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities

Publications (2)

Publication Number Publication Date
RU93058393A true RU93058393A (en) 1996-04-27
RU2125983C1 RU2125983C1 (en) 1999-02-10

Family

ID=10709721

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058393A RU2125983C1 (en) 1992-02-03 1993-02-01 Ethanolamine derivatives, method of their synthesis, pharmaceutical composition, method of treatment

Country Status (3)

Country Link
GB (1) GB9202236D0 (en)
RU (1) RU2125983C1 (en)
ZA (1) ZA93591B (en)

Similar Documents

Publication Publication Date Title
RU2215746C2 (en) Heterocyclic derivatives of glycyl-beta-alanine as antagonists of vitronectin
RU2000127751A (en) ANTI-TUMOR MEDICINE
RU2002107975A (en) GLUCOPYANANOSYLOXYPYRAZOLIC DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THESE DERIVATIVES, AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION
EA200000592A1 (en) AZAPOLICYCLIC COMPOUNDS CONDENSED WITH ARYL
RU93058555A (en) Quinuclidine derivatives, a method for their production, a pharmaceutical composition, a method for the treatment or prevention
DE69113155D1 (en) 17-BETA-SUBSTITUTED-4-AZA-5-ALPHA-ANDROSTAN-3-ONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
KR890013035A (en) Indolocarbazole derivatives, preparation method thereof and pharmaceutical composition containing them
RU98111511A (en) TRICYCLIC PYRAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION
KR920009796A (en) 3-amidoindolyl derivatives
DK0583485T3 (en) Ethanolamine derivatives with sympathomimetic and anti-pollakisuria effects
RU97117350A (en) INTIMA HYPERTROPHY INHIBITOR, OXINDOL DERIVATIVE APPLICATION FOR THE INIMA HYPERTROPHY INHIBITOR INHIBITOR, A COMPOSITION FOR INHIBITING INTIMA HYPERTROPHY, PREVENTION AND TREATMENT HYPERT
ES538418A0 (en) A DERIVATIVE OF INDOL-3-CARBOXAMIDE
RU95117068A (en) ANTIHYPERTRIGLICYRIDEMIC COMPOSITION, METHOD FOR PRODUCING IT, METHOD FOR TREATING OR PREVENTION OF HYPERTRIGLYCERIDEMIA, USE OF COMPOUNDS
RU96105034A (en) CONDENSED INDAN DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
KR890011596A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for treating insomnia
DE3483798D1 (en) DIHYDRODIBENZOCYCLOHEPTYLIDENETHYLAMINE DERIVATIVES.
DE3686979D1 (en) CEPHEM CONNECTIONS AND METHOD FOR THEIR PRODUCTION.
RU2000128647A (en) INTEGRATED PLATINUM CONNECTION, METHODS FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION
RU93058393A (en) ETHANOLAMINE DERIVATIVES THAT DISTRIBUTE SYMPATHOMOMETIC AND ANTIPOLAKIURIAL ACTIVITY, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
RU2001113272A (en) 3-Tetrahydropyridine-4-ylindoles for the treatment of psychotic disorders
RU2003130062A (en) BICYCLIC DERIVATIVES OF GUANIDINE AND THEIR THERAPEUTIC USE
RU2000102642A (en) MEDICAL MEANS AGAINST AloPETIA
RU2347783C2 (en) Diazepane derivatives, their use as lfa inhibitors, method of curing diseases caused by reaction with lfa-1/icam-1
KR940005541A (en) Substituted Benzoate Derivatives
RU96123896A (en) DERIVATIVES OF AMIDES OF ACIDS AND METHOD OF THEIR PRODUCTION